Кафедра педіатрії № 2

Постійне посилання на фонд

https://repository.pdmu.edu.ua/handle/123456789/39

Переглянути

Перегляд Кафедра педіатрії № 2 за Автор "Bobyrova, L. E."

Зараз показуємо 1 - 2 з 2
  • Ескіз недоступний
    Документ
    Optimization of pharmacotherapy of chronic obstructive pulmonary disease complicated by bronhoectasis in patients with cardiovascular pathology
    (Towarzystwo Wydawnictw Naukowych LIBROPOLIS Sp. z o.o., 2014) Bobyrova, L. E.; Vakhnenko, A. V.; Moiseeva, N. V.; Rumiantseva, M. A.; Бобирьова, Людмила Єгорівна; Вахненко, Андрій Вікторович; Рум'янцева, Марія Олександрівна; Моісєєва, Наталія Віталіївна
    Chronic obstructive pulmonary disease is a weighty social health and economic importance, and remains one of the major causes of morbidity and mortality worldwide. Presently, special attention is paid to comorbid conditions, when the patient has a combination of pathology respiratory and cardiovascular systems. This research has been devoted to finding ways to optimize the treatment of moderate acute exacerbations of chronic obstructive pulmonary disease with the complication of bronchoectasis on the background of coronary heart disease.
  • Ескіз недоступний
    Документ
    Rotavirus Infection in Children as of Today (Literature Review)
    (Wydawnictwo Aluna, 2017) Pikul, K. V.; Bobyrova, L. E.; Kushnereva, T. V.; Il'chenko, V. I.; Priluckiy, K. Yu.; Пікуль, Катерина Вікторівна; Бобирьова, Людмила Єгорівна; Кушнерева, Тетяна Вікторівна; Ільченко, Валентина Іванівна; Прилуцький, Костянтин Юрійович
    Urgency of the issue of rotavirus infection is stipulated by a special place in the structure of morbidity and mortality among young children. According to the data provided by WHO, 180 million diarrheal diseases with rotavirus etiology are registered every year. In Europe, 25 million children at the age of 5 years and younger are in need of medical care, and there are 2 million among them hospitalized each year. The specific prophylaxis is recommended in order to prevent these phenomena. Rotarix vaccine, which has cross protection against different strains (G1, G2, G3, G4 and G9), and RotaTed vaccine containing G serotypes (human serotypes G1, G2, G3, G4 and P1A and bovine serotypes G6, P7) are recommended.